New Delhi – The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB(Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals from Govt for commercial launch.
The Tata CRISPR test is the world’s first diagnostic test to deploy a speciallyadapted Cas9 protein to successfully detect the virus causing Covid-19.
This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus.CRISPR is a genome editing technology to diagnosing diseases.
